{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:26:49Z","timestamp":1792661209863,"version":"4.5.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/ico.0b013e31819839f9","type":"journal-article","created":{"date-parts":[[2009,9,18]],"date-time":"2009-09-18T08:36:50Z","timestamp":1253263010000},"page":"1070-1073","source":"Crossref","is-referenced-by-count":44,"title":["Subconjunctival and Intracorneal Bevacizumab Injection for Corneal Neovascularization in Lipid Keratopathy"],"prefix":"10.1097","volume":"28","author":[{"given":"Joo Youn","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mee Kum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Ryang","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210227","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archopht.123.10.1435","article-title":"Unusual idiopathic lipid keratopathy: a newly recognized entity?","volume":"123","author":"Loeffler","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R2-23-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198607033150110","article-title":"Advances in corneal transplantation.","volume":"315","author":"Lindstrom","year":"1986","journal-title":"N Engl J Med"},{"key":"R3-23-20210227","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/bjo.48.8.416","article-title":"Comparative study of the action of thiotepa and triamcinolone on corneal vascularisation in rabbits.","volume":"48","author":"Laverage","year":"1964","journal-title":"Br J Ophthalmol"},{"key":"R4-23-20210227","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0009-9260(62)80005-1","article-title":"Treatment of corneal vascularisation by Strontium 90 beta plaque.","volume":"13","author":"Ainslie","year":"1962","journal-title":"Clin Radiol"},{"key":"R5-23-20210227","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archopht.1967.00980020639013","article-title":"Cryotherapy in corneal vascularisation.","volume":"77","author":"Mayer","year":"1967","journal-title":"Arch Ophthalmol"},{"key":"R6-23-20210227","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/bjo.72.12.900","article-title":"Argon laser treatment of lipid keratopathy.","volume":"72","author":"Marsh","year":"1988","journal-title":"Br J Ophthalmol"},{"key":"R7-23-20210227","first-page":"2148","article-title":"Fine needle diathermy occlusion of corneal vessels.","volume":"41","author":"Pillai","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R8-23-20210227","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.ico.0000248383.09272.ee","article-title":"Electrolysis-needle cauterization of corneal vessels in patients with lipid keratopathy.","volume":"26","author":"Wertheim","year":"2007","journal-title":"Cornea"},{"key":"R9-23-20210227","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ophtha.2006.05.070","article-title":"Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study.","volume":"113","author":"Moshfeghi","year":"2006","journal-title":"Ophthalmology"},{"key":"R10-23-20210227","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"R11-23-20210227","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","article-title":"The effect of topical bevacizumab on corneal neovascularization.","volume":"115","author":"Kim","year":"2008","journal-title":"Ophthalmology"},{"key":"R12-23-20210227","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/ICO.0b013e318158f6ad","article-title":"Topical bevacizumab and ocular surface neovascularization in patients with Stevens-Johnson syndrome.","volume":"27","author":"Uy","year":"2008","journal-title":"Cornea"},{"key":"R13-23-20210227","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.ico.0000611440.32234.8f","article-title":"Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis.","volume":"27","author":"Carrasco","year":"2008","journal-title":"Cornea"},{"key":"R14-23-20210227","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/02713680701799101","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium.","volume":"33","author":"Bahar","year":"2008","journal-title":"Curr Eye Res"},{"key":"R15-23-20210227","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/ICO.0b013e318159019f","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization.","volume":"27","author":"Bahar","year":"2008","journal-title":"Cornea"},{"key":"R16-23-20210227","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis.","volume":"91","author":"DAmato","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"R17-23-20210227","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).","volume":"104","author":"Azar","year":"2006","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R18-23-20210227","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R19-23-20210227","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","article-title":"Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.","volume":"48","author":"Bock","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-23-20210227","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjo.2006.107912","article-title":"Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin).","volume":"91","author":"Manzano","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R21-23-20210227","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/ICO.0b013e318160d019","article-title":"Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs.","volume":"27","author":"Hurmeric","year":"2008","journal-title":"Cornea"},{"key":"R22-23-20210227","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ajo.2007.11.003","article-title":"Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model.","volume":"145","author":"Papathanassiou","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R23-23-20210227","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1442-9071.2007.01572.x","article-title":"Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis.","volume":"35","author":"Hosseini","year":"2007","journal-title":"Clin Exp Ophthalmol"},{"key":"R24-23-20210227","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1590\/S0001-37652007000300004","article-title":"The effects of the subconjunctival injection of bevacizumab (Avastin) on angiogenesis in the rat cornea.","volume":"79","author":"Barros","year":"2007","journal-title":"An Acad Bras Cienc"},{"key":"R25-23-20210227","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1167\/iovs.07-1418","article-title":"Vascular endothelial growth factor mediates corneal nerve repair.","volume":"49","author":"Yu","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003226-200910000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:59:34Z","timestamp":1786039174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-200910000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31819839f9","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}